Analyst Ratings For Fulgent Genetics (NASDAQ:FLGT)
Today, Credit Suisse Group lowered its price target on Fulgent Genetics (NASDAQ:FLGT) to $6.00 per share.
Some recent analyst ratings include
- 3/1/2018-Piper Jaffray Companies was Downgraded by analysts at Piper Jaffray Companies from a “Overweight ” rating to a ” Neutral” rating.
- 11/7/2017-Raymond James Financial was Downgraded by analysts at Raymond James Financial from a “Outperform ” rating to a ” Mkt Perform” rating.
- 10/24/2016-BTIG Research initiated coverage with a Buy rating.
Recent Insider Trading Activity For Fulgent Genetics (NASDAQ:FLGT)
Fulgent Genetics (NASDAQ:FLGT) has insider ownership of 58.80% and institutional ownership of 11.85%.
- On 11/30/2017 Ming Hsieh, Insider, bought 2,000 with an average share price of $3.60 per share and the total transaction amounting to $7,200.00.
- On 11/20/2017 Ming Hsieh, CEO, bought 7,259 with an average share price of $3.28 per share and the total transaction amounting to $23,809.52.
- On 11/16/2017 Ming Hsieh, Insider, bought 2,205 with an average share price of $3.23 per share and the total transaction amounting to $7,122.15.
- On 11/14/2017 Ming Hsieh, Insider, bought 10,504 with an average share price of $3.30 per share and the total transaction amounting to $34,663.20.
- On 11/13/2017 Paul Kim, CFO, sold 1,573 with an average share price of $3.22 per share and the total transaction amounting to $5,065.06.
- On 11/9/2017 Ming Hsieh, CEO, bought 11,520 with an average share price of $3.47 per share and the total transaction amounting to $39,974.40.
- On 8/11/2017 Paul Kim, CFO, sold 6,134 with an average share price of $5.71 per share and the total transaction amounting to $35,025.14.
Recent Trading Activity for Fulgent Genetics (NASDAQ:FLGT)
Shares of Fulgent Genetics closed the previous trading session at 4.34 down -0.45 9.40% with 4.579999923706055 shares trading hands.
